Implantable Cardioverter-Defibrillator Therapy Before Death | Zendy

Annika Kinch Westerdahl | Zendy; Johanna Sjöblom | Zendy; AnneCathrine Mattiasson | Zendy; Mårten Rosenqvist | Zendy; Viveka Frykman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Implantable Cardioverter-Defibrillator Therapy Before Death

Author(s) -

Annika Kinch Westerdahl,

Johanna Sjöblom,

AnneCathrine Mattiasson,

Mårten Rosenqvist,

Viveka Frykman

Publication year - 2013

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.113.002648

Subject(s) - medicine , ventricular fibrillation , cardiology , implantable cardioverter defibrillator , sudden cardiac death , heart failure , ventricular tachycardia , cause of death , incidence (geometry) , shock (circulatory) , intracardiac injection , sudden death , population , disease , physics , environmental health , optics

Several trials have demonstrated improved survival with implantable cardioverter-defibrillator (ICD) therapy. The cause and nature of death in the ICD population have been insufficiently investigated. The objective of this study was to analyze ICDs from deceased patients to assess the incidence of ventricular tachyarrhythmias, the occurrence of shocks, and possible device malfunction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research